Biogen Eisai's Leqembi Alzheimer's drug rejected by EU regulator

European drug regulators on Friday rejected Leqembi's Alzheimer's treatment Biogen and Eisaicreating another hurdle for companies as they struggle to…

Bristol Myers Squibb (BMY) Q2 2024 Results

Bristol Myers Squibb's research and development center at Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023. Adam Glanzman |…

Hasbro (HAS) Q2 2024 Earnings

Hasbro board games are seen for sale at a Target store on December 12, 2023 in Austin, Texas. Brandon Bell…